Tower Research Capital (TRC)’s Prelude Therapeutics PRLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.6K | Buy |
|
|||||
|
2025
Q1 | $10.4K | Buy |
|
|||||
|
2024
Q4 | $13.2K | Buy |
|
|||||
|
2024
Q3 | $11K | Sell |
|
|||||
|
2024
Q2 | $26.9K | Buy |
|
|||||
|
2024
Q1 | $15.9K | Sell |
|
|||||
|
2023
Q4 | $17K | Buy |
|
|||||
|
2023
Q3 | $10.8K | Buy |
|
|||||
|
2023
Q2 | $9.4K | Sell |
|
|||||
|
2023
Q1 | $76K | Buy |
|
|||||
|
2022
Q4 | $21K | Buy |
|
|||||
|
2022
Q3 | $9K | Sell |
|
|||||
|
2022
Q2 | $21K | Buy |
|
|||||
|
2022
Q1 | $16K | Sell |
|
|||||
|
2021
Q4 | $66K | Buy |
|
|||||
|
2021
Q3 | $109K | Buy |
|
|||||
|
2021
Q2 | $31K | Sell |
|
|||||
|
2021
Q1 | $122K | Buy |
|
|||||
|
2020
Q4 | $15K | Buy |
|